Windlas Biotech Limited (NSE:WINDLAS)

Windlas Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	18,878	21,747	10,614	4,715	4,578	-
Market Cap Growth	104.90%	104.90%	125.11%	2.99%	-	-
Enterprise Value	16,811	19,806	8,990	2,946	2,605	-
Last Close Price	903.25	1040.50	507.15	221.61	203.58	-
PE Ratio	31.29	35.65	18.24	11.06	12.02	-
PS Ratio	2.48	2.86	1.68	0.92	0.98	-
PB Ratio	3.73	4.30	2.36	1.17	1.16	-
P/TBV Ratio	3.78	4.36	2.38	1.18	1.16	-
P/FCF Ratio	118.04	135.98	14.89	-	-	-
P/OCF Ratio	27.69	31.89	9.74	7.73	50.14	-
EV/Sales Ratio	2.21	2.61	1.43	0.57	0.56	-
EV/EBITDA Ratio	17.86	21.05	11.80	5.02	5.05	-
EV/EBIT Ratio	25.42	29.95	13.89	6.15	6.47	-
EV/FCF Ratio	105.12	123.84	12.61	-	-	-
Debt / Equity Ratio	0.06	0.06	0.01	0.01	0.02	0.16
Debt / EBITDA Ratio	0.35	0.35	0.05	0.08	0.13	0.58
Debt / FCF Ratio	2.04	2.04	0.05	-	-	5.77
Asset Turnover	1.10	1.10	1.09	1.01	1.18	1.35
Inventory Turnover	6.57	6.57	5.85	4.94	6.15	6.15
Quick Ratio	1.63	1.63	1.99	2.06	3.08	1.43
Current Ratio	2.11	2.11	2.51	2.92	4.06	2.08
Return on Equity (ROE)	12.76%	12.76%	13.66%	10.70%	12.83%	7.62%
Return on Assets (ROA)	5.96%	5.96%	7.00%	5.87%	6.40%	8.55%
Return on Capital (ROIC)	8.33%	8.33%	9.40%	7.40%	7.95%	11.54%
Return on Capital Employed (ROCE)	12.90%	12.90%	14.20%	11.70%	10.10%	21.40%
Earnings Yield	3.23%	2.80%	5.48%	9.04%	8.32%	-
FCF Yield	0.85%	0.73%	6.72%	-2.10%	-1.24%	-
Dividend Yield	0.64%	0.56%	1.08%	1.80%	1.72%	-
Payout Ratio	18.85%	18.85%	14.27%	17.89%	-	-
Buyback Yield / Dilution	-1.22%	-1.22%	3.53%	-5.56%	-12.58%	-
Total Shareholder Return	-0.58%	-0.66%	4.61%	-3.75%	-10.86%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.